Human Apolipoprotein A-I Kinetics Within Triglyceride-rich Lipoproteins and High Density Lipoproteins
Overview
Affiliations
Stable isotope methodology was used to determine the kinetic behavior of apolipoprotein (apo) A-I within the triglyceride-rich lipoprotein (TRL) fraction and to compare TRL apoA-I kinetics with that of apoA-I in high density lipoprotein (HDL) and TRL apoB-48. Eight subjects (5 males and 3 females) over the age of 40 were placed on a baseline average American diet and after 6 weeks received a primed-constant infusion of [5,5,5-(2)H(3)]-l-leucine for 15 h while consuming small hourly meals of identical composition. HDL and TRL apoA-I and TRL apoB-48 tracer/tracee enrichment curves were obtained by gas chromatography;-mass spectrometry. Data were fitted to a compartmental model to determine the fractional secretion rates of apoA-I and apoB-48 within each lipoprotein fraction. Mean plasma apoA-I levels in TRL and HDL fractions were 0. 204 +/- 0.057 and 134 +/- 15 mg/dl, respectively. The mean fractional catabolic rate (FCR) of TRL apoA-I was 0.250 +/- 0.069 and HDL apoA-I was 0.239 +/- 0.054 pools/day, with mean estimated residence times (RT) of 4.27 and 4.37 days, respectively. The mean TRL apoB-48 FCR was 5.2 +/- 2.0 pools/day and the estimated mean RT was 5.1 +/- 1.8 h. Our results indicate that apoA-I is catabolized at a slower rate than apoB-48 within TRL, and that apoA-I within TRL and HDL fractions are catabolized at similar rates.
Chetiveaux M, Croyal M, Ouguerram K, Fall F, Flet L, Zair Y Sci Rep. 2020; 10(1):15585.
PMID: 32973209 PMC: 7519065. DOI: 10.1038/s41598-020-72323-w.
Andraski A, Singh S, Ho Lee L, Higashi H, Smith N, Zhang B Arterioscler Thromb Vasc Biol. 2019; 39(11):2411-2430.
PMID: 31554421 PMC: 6874109. DOI: 10.1161/ATVBAHA.119.312889.
Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.
Verges B, Florentin E, Baillot-Rudoni S, Petit J, Brindisi M, Pais de Barros J J Lipid Res. 2009; 50(6):1209-15.
PMID: 19168444 PMC: 2681403. DOI: 10.1194/jlr.P800040-JLR200.
Matthan N, Jalbert S, Barrett P, Dolnikowski G, Schaefer E, Lichtenstein A Arterioscler Thromb Vasc Biol. 2008; 28(10):1838-43.
PMID: 18658047 PMC: 2872098. DOI: 10.1161/ATVBAHA.108.163931.
Lipoprotein metabolism in chronic renal insufficiency.
Saland J, Ginsberg H Pediatr Nephrol. 2007; 22(8):1095-112.
PMID: 17390152 DOI: 10.1007/s00467-007-0467-5.